A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients

Transplantation Proceedings

Volumn 37, Issue 10, 2005, Pages 4303-4305

  John, G T ^a   Manivannan, J ^a   Chandy, S ^a   Peter, S ^a   Fleming, D H ^a   Chandy, S J ^a   Balakrishnan, N ^a   Krishnamurthy, K ^a   Kirubakaran, M G ^a   Jacob, C K ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLEFT; DRUG METABOLITE; GANCICLOVIR; LEFLUNOMIDE; TERIFLUNOMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG COST; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL TRACT; GRAFT RECIPIENT; HISTOLOGY; HUMAN; INFORMED CONSENT; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; PLASMA CLEARANCE; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RELAPSE; VIREMIA;

ADULT; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; ISOXAZOLES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 29544450244     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.10.116     Document Type: Article

References (9)

1. M. Rao, G.J. Finny, P. Abraham Cytomegalovirus infection in a seroendemic renal transplant population a longitudinal study of virological markers Nephron 84 2000 367
2. P. Mukundan, M. Jadhav, T.J. John Prevalence of CMV antibody in young children in Vellore Indian J Med Res 65 1977 589
3. G.T. John, V. Shankar, G.S. Talaulikar Epidemiology of systemic mycoses among renal transplant recipients in India Transplantation 75 2003 1544
4. G.T. John, V. Shankar, U. Mukundan Risk factors for post transplant tuberculosis Kidney Int 60 2001 1148
5. V. Kher End stage renal disease in developing countries Kidney Int 62 2002 350
6. W.J. Waldman, D.A. Knight, L. Blinder Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide Intervirology 42 1999 412
7. G.T. John, J. Manivannan, S. Chandy Leflunomide therapy for cytomegalovirus disease in renal allograft recipients Transplantation 77 2004 1460
8. C. Mengelle, K. Sandres-Saune, C. Pasquier Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay J Clin Microbiol 41 2003 3840
9. R. Williamson, C. Yea, P. Robson Dihydroorotate dehydrogenase is a high affinity binding protein for A 77 1726 and mediator of a range of biological effects of the immunomodulatory compound J Biol Chem 270 1995 22467